Xavi Suárez Calvet
Xavi Suárez Calvet
Neuromuscular Disorders Unit, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain
Dirección de correo verificada de santpau.cat
Título
Citado por
Citado por
Año
Long-lasting treatment effect of rituximab in MuSK myasthenia
J Díaz-Manera, E Martínez-Hernández, L Querol, R Klooster, ...
Neurology 78 (3), 189-193, 2012
2602012
Antibodies to contactin‐1 in chronic inflammatory demyelinating polyneuropathy
L Querol, G Nogales‐Gadea, R Rojas‐Garcia, E Martinez‐Hernandez, ...
Annals of neurology 73 (3), 370-380, 2013
2192013
Altered RIG‐I/DDX58‐mediated innate immunity in dermatomyositis
X Suárez‐Calvet, E Gallardo, G Nogales‐Gadea, L Querol, M Navas, ...
The Journal of pathology 233 (3), 258-268, 2014
642014
JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis
L Ladislau, X Suárez-Calvet, S Toquet, O Landon-Cardinal, D Amelin, ...
Brain 141 (6), 1609-1621, 2018
602018
A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss
E Servián‐Morilla, H Takeuchi, TV Lee, J Clarimon, F Mavillard, ...
EMBO molecular medicine 8 (11), 1289-1309, 2016
542016
Dermatomyositis with or without anti-melanoma differentiation-associated gene 5 antibodies: common interferon signature but distinct NOS2 expression
Y Allenbach, G Leroux, X Suárez-Calvet, C Preusse, E Gallardo, ...
The American Journal of Pathology 186 (3), 691-700, 2016
462016
Role of thrombospondin 1 in macrophage inflammation in dysferlin myopathy
N De Luna, E Gallardo, C Sonnet, B Chazaud, R Dominguez-Perles, ...
Journal of Neuropathology & Experimental Neurology 69 (6), 643-653, 2010
352010
Analysis of serum miRNA profiles of myasthenia gravis patients
G Nogales-Gadea, A Ramos-Fransi, X Suarez-Calvet, M Navas, ...
PloS one 9 (3), e91927, 2014
322014
RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis
X Suárez-Calvet, E Gallardo, I Pinal-Fernandez, N De Luna, C Lleixà, ...
Arthritis research & therapy 19 (1), 1-7, 2017
182017
Platelet-derived growth factor BB influences muscle regeneration in Duchenne muscle dystrophy
P Piñol-Jurado, E Gallardo, N de Luna, X Suárez-Calvet, ...
The American Journal of Pathology 187 (8), 1814-1827, 2017
152017
Hypoxia triggers IFN-I production in muscle: Implications in dermatomyositis
N De Luna, X Suárez-Calvet, C Lleixà, J Diaz-Manera, M Olivé, I Illa, ...
Scientific reports 7 (1), 1-9, 2017
112017
Nintedanib decreases muscle fibrosis and improves muscle function in a murine model of dystrophinopathy
P Piñol-Jurado, X Suárez-Calvet, E Fernández-Simón, E Gallardo, ...
Cell death & disease 9 (7), 1-15, 2018
92018
Bone marrow transplantation in dysferlin-deficient mice results in a mild functional improvement
B Flix, X Suárez-Calvet, J Díaz-Manera, E Santos-Nogueira, R Mancuso, ...
Stem cells and development 22 (21), 2885-2894, 2013
72013
Identification of serum microRNAs as potential biomarkers in Pompe disease
A Carrasco‐Rozas, E Fernández‐Simón, MC Lleixà, I Belmonte, ...
Annals of clinical and translational neurology 6 (7), 1214-1224, 2019
62019
PDGF-BB serum levels are decreased in adult onset Pompe patients
E Fernández-Simón, A Carrasco-Rozas, E Gallardo, ...
Scientific reports 9 (1), 1-10, 2019
32019
Thrombospondin-1 mediates muscle damage in brachio-cervical inflammatory myopathy and systemic sclerosis
X Suárez-Calvet, J Alonso-Pérez, I Castellví, A Carrasco-Rozas, ...
Neurology-Neuroimmunology Neuroinflammation 7 (3), 2020
22020
Effect of MAPK inhibition on the differentiation of a rhabdomyosarcoma cell line combined with CRISPR/Cas9 technology: An in vitro model of human muscle diseases
N De Luna, X Suarez-Calvet, M Garicano, E Fernandez-Simon, ...
Journal of Neuropathology & Experimental Neurology 77 (10), 964-972, 2018
22018
Study of the effect of anti-rhGAA antibodies at low and intermediate titers in late onset Pompe patients treated with ERT
E Fernández-Simón, A Carrasco-Rozas, E Gallardo, L González-Quereda, ...
Molecular Genetics and Metabolism 128 (1-2), 129-136, 2019
12019
Persistent abnormal TLR response and the effect of IVIg on TLR7 in Guillain-Barré syndrome patients
X Suárez-Calvet, E Gallardo, G Nogales-Gadea, L Querol, R Rojas-Garca, ...
Journal of the Peripheral Nervous System 18, 2013
12013
Proteasome Inhibitors Reduce Thrombospondin-1 Release in Human Dysferlin-Deficient Myotubes
E Fernández-Simón, C Lleixà, X Suarez-Calvet, J Diaz-Manera, I Illa, ...
2020
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20